162 related articles for article (PubMed ID: 27991916)
1. The HIF/PHF8/AR axis promotes prostate cancer progression.
Tong D; Liu Q; Liu G; Yuan W; Wang L; Guo Y; Lan W; Zhang D; Dong S; Wang Y; Xiao H; Mu J; Mao C; Wong J; Jiang J
Oncogenesis; 2016 Dec; 5(12):e283. PubMed ID: 27991916
[TBL] [Abstract][Full Text] [Related]
2. Histone demethylase PHF8 regulates hypoxia signaling through HIF1α and H3K4me3.
Maina PK; Shao P; Jia X; Liu Q; Umesalma S; Marin M; Long D; Concepción-Román S; Qi HH
Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):1002-1012. PubMed ID: 28734980
[TBL] [Abstract][Full Text] [Related]
3. c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer.
Maina PK; Shao P; Liu Q; Fazli L; Tyler S; Nasir M; Dong X; Qi HH
Oncotarget; 2016 Nov; 7(46):75585-75602. PubMed ID: 27689328
[TBL] [Abstract][Full Text] [Related]
4. Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion.
Björkman M; Östling P; Härmä V; Virtanen J; Mpindi JP; Rantala J; Mirtti T; Vesterinen T; Lundin M; Sankila A; Rannikko A; Kaivanto E; Kohonen P; Kallioniemi O; Nees M
Oncogene; 2012 Jul; 31(29):3444-56. PubMed ID: 22120715
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits hypoxia-inducible factor-1α-mediated androgen receptor signaling and represses tumor progression in castration-resistant prostate cancer.
Mitani T; Harada N; Tanimori S; Nakano Y; Inui H; Yamaji R
J Nutr Sci Vitaminol (Tokyo); 2014; 60(4):276-82. PubMed ID: 25297617
[TBL] [Abstract][Full Text] [Related]
6. The histone demethylase PHF8 promotes prostate cancer cell growth by activating the oncomiR miR-125b.
Ma Q; Chen Z; Jia G; Lu X; Xie X; Jin W
Onco Targets Ther; 2015; 8():1979-88. PubMed ID: 26309412
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
McGrath MJ; Binge LC; Sriratana A; Wang H; Robinson PA; Pook D; Fedele CG; Brown S; Dyson JM; Cottle DL; Cowling BS; Niranjan B; Risbridger GP; Mitchell CA
Cancer Res; 2013 Aug; 73(16):5066-79. PubMed ID: 23801747
[TBL] [Abstract][Full Text] [Related]
8. Histone demethylase PHF8 promotes progression and metastasis of gastric cancer.
Li S; Sun A; Liang X; Ma L; Shen L; Li T; Zheng L; Shang W; Zhao W; Jia J
Am J Cancer Res; 2017; 7(3):448-461. PubMed ID: 28401003
[TBL] [Abstract][Full Text] [Related]
9. The histone demethylase PHF8 is an oncogenic protein in human non-small cell lung cancer.
Shen Y; Pan X; Zhao H
Biochem Biophys Res Commun; 2014 Aug; 451(1):119-25. PubMed ID: 25065740
[TBL] [Abstract][Full Text] [Related]
10. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK
Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197
[TBL] [Abstract][Full Text] [Related]
11. A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer.
Gu P; Chen X; Xie R; Xie W; Huang L; Dong W; Han J; Liu X; Shen J; Huang J; Lin T
Mol Cancer; 2019 Jun; 18(1):109. PubMed ID: 31221168
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52.
Joshi JB; Patel D; Morton DJ; Sharma P; Zou J; Hewa Bostanthirige D; Gorantla Y; Nagappan P; Komaragiri SK; Sivils JC; Xie H; Palaniappan R; Wang G; Cox MB; Chaudhary J
Mol Oncol; 2017 Apr; 11(4):337-357. PubMed ID: 28252832
[TBL] [Abstract][Full Text] [Related]
13. Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer.
Zheng D; Gui B; Gray KP; Tinay I; Rafiei S; Huang Q; Sweeney CJ; Kibel AS; Jia L
Oncogene; 2016 Sep; 35(36):4807-15. PubMed ID: 26876202
[TBL] [Abstract][Full Text] [Related]
14. Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription.
Jia L; Wu D; Wang Y; You W; Wang Z; Xiao L; Cai G; Xu Z; Zou C; Wang F; Teoh JY; Ng CF; Yu S; Chan FL
Oncogene; 2018 Jun; 37(25):3340-3355. PubMed ID: 29555975
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
Shafi AA; Yen AE; Weigel NL
Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
[TBL] [Abstract][Full Text] [Related]
16. HIF1α expression under normoxia in prostate cancer--which pathways to target?
Ranasinghe WK; Baldwin GS; Bolton D; Shulkes A; Ischia J; Patel O
J Urol; 2015 Mar; 193(3):763-70. PubMed ID: 25444956
[TBL] [Abstract][Full Text] [Related]
17. The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway.
Wang L; Song G; Chang X; Tan W; Pan J; Zhu X; Liu Z; Qi M; Yu J; Han B
Oncogene; 2015 Sep; 34(36):4735-45. PubMed ID: 25500540
[TBL] [Abstract][Full Text] [Related]
18. The X-linked mental retardation gene PHF8 is a histone demethylase involved in neuronal differentiation.
Qiu J; Shi G; Jia Y; Li J; Wu M; Li J; Dong S; Wong J
Cell Res; 2010 Aug; 20(8):908-18. PubMed ID: 20548336
[TBL] [Abstract][Full Text] [Related]
19. Plant Homeo Domain Finger Protein 8 Regulates Mesodermal and Cardiac Differentiation of Embryonic Stem Cells Through Mediating the Histone Demethylation of pmaip1.
Tang Y; Hong YZ; Bai HJ; Wu Q; Chen CD; Lang JY; Boheler KR; Yang HT
Stem Cells; 2016 Jun; 34(6):1527-40. PubMed ID: 26866517
[TBL] [Abstract][Full Text] [Related]
20. Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells.
Horii K; Suzuki Y; Kondo Y; Akimoto M; Nishimura T; Yamabe Y; Sakaue M; Sano T; Kitagawa T; Himeno S; Imura N; Hara S
Mol Cancer Res; 2007 Apr; 5(4):383-91. PubMed ID: 17426252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
